<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Acrivon Therapeutics, Inc. (ACRV) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/acrv/filings</link>
    <description>Latest company filings for Acrivon Therapeutics, Inc. (ACRV) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Sat, 11 Jul 2026 21:53:24 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/acrv/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002652/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002652</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-26.]]></description>
      <pubDate>Tue, 26 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000119312526236858/acrv-20260522.htm</link>
      <guid isPermaLink="false">0001193125-26-236858</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Proxy materials (DEFA14A) on 2026-05-22.]]></description>
      <pubDate>Fri, 22 May 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000123191926000517/xslF345X06/form4-05202026_080548.xml</link>
      <guid isPermaLink="false">0001231919-26-000517</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002563/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002563</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002562/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002562</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002560/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002560</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002559/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002559</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002558/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002558</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002557/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002557</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002556/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002556</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002555/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002555</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002553/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002553</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002552/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002552</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002551/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002551</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002550/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002550</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002549/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002549</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002502/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002502</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002501/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002501</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002500/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002500</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002499/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002499</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826002498/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002498</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000110465926062728/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-26-062728</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000119312526221634/acrv-20260331.htm</link>
      <guid isPermaLink="false">0001193125-26-221634</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Quarterly report (10-Q) on 2026-05-13.]]></description>
      <pubDate>Wed, 13 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000119312526221626/acrv-20260513.htm</link>
      <guid isPermaLink="false">0001193125-26-221626</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Major company event (8-K) on 2026-05-13.]]></description>
      <pubDate>Wed, 13 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000119312526194214/2026_ars.pdf</link>
      <guid isPermaLink="false">0001193125-26-194214</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Annual report to shareholders (ARS) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000119312526194211/acrv-20260428.htm</link>
      <guid isPermaLink="false">0001193125-26-194211</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Proxy materials (DEFA14A) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000119312526194206/acrv-20260430.htm</link>
      <guid isPermaLink="false">0001193125-26-194206</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Proxy statement (DEF 14A) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[ACRV: SCHEDULE 13D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000134682426000116/xslSCHEDULE_13D_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001346824-26-000116</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a SCHEDULE 13D/A (SCHEDULE 13D/A) on 2026-04-23.]]></description>
      <pubDate>Thu, 23 Apr 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D/A</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000123191926000396/xslF345X06/form4-04232026_080403.xml</link>
      <guid isPermaLink="false">0001231919-26-000396</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-04-23.]]></description>
      <pubDate>Thu, 23 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826001768/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-001768</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-04-21.]]></description>
      <pubDate>Tue, 21 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: SCHEDULE 13D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000134682426000081/xslSCHEDULE_13D_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001346824-26-000081</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a SCHEDULE 13D/A (SCHEDULE 13D/A) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D/A</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000119312526115150/d390264ds8.htm</link>
      <guid isPermaLink="false">0001193125-26-115150</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Employee stock plan (S-8) on 2026-03-19.]]></description>
      <pubDate>Thu, 19 Mar 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000119312526115139/acrv-20260319.htm</link>
      <guid isPermaLink="false">0001193125-26-115139</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-19.]]></description>
      <pubDate>Thu, 19 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000119312526115123/acrv-20251231.htm</link>
      <guid isPermaLink="false">0001193125-26-115123</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Annual report (10-K) on 2026-03-19.]]></description>
      <pubDate>Thu, 19 Mar 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826001121/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-001121</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826001120/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-001120</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826001119/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-001119</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826001118/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-001118</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826001117/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-001117</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826001116/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-001116</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826001115/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-001115</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000119312526085516/d111455d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-085516</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000119312526079500/d116670d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-079500</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Major company event (8-K) on 2026-02-27.]]></description>
      <pubDate>Fri, 27 Feb 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826001010/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-001010</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-02-24.]]></description>
      <pubDate>Tue, 24 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826000939/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-000939</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-02-18.]]></description>
      <pubDate>Wed, 18 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826000937/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-000937</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-02-18.]]></description>
      <pubDate>Wed, 18 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826000936/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-000936</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-02-18.]]></description>
      <pubDate>Wed, 18 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826000935/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-000935</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-02-18.]]></description>
      <pubDate>Wed, 18 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826000934/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-000934</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-02-18.]]></description>
      <pubDate>Wed, 18 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRV: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1781174/000090514826000281/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-000281</guid>
      <description><![CDATA[Acrivon Therapeutics, Inc. filed a Insider trade (4) on 2026-01-21.]]></description>
      <pubDate>Wed, 21 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
  </channel>
</rss>